AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With Schizophrenia
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.010
https://www.valueinhealthjournal.com/article/S1098-3015(11)01572-5/fulltext
Title :
AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With Schizophrenia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01572-5&doi=10.1016/j.jval.2011.08.010
First page :
A233
Section Title :
Assessing Effect of Medication Adherence and Persistence on Cost-Effectiveness
Open access? :
No
Section Order :
1